Photo via Pixabay San Diego-based medical technology company Illumina announced Monday that it has submitted a registration statement to the U.S. Securities and Exchange Commission regarding its potential divestiture of cancer detection test developer Grail. Illumina was ordered by both the European Union and the Federal Trade Commission to divest its $7.1 billion acquisition of Grail over allegations the deal was anti-competitive. Illumina is still challenging both orders in court, but said the submission of the registration statement “is an important next step in evaluating divestiture options for Grail.” The company says it will divest Grail if its legal challenges are unsuccess
Hence then, the article about illumina submits registration statement to sec for potential grail divestiture was published today ( ) and is available onTimes of San Diego ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Illumina Submits Registration Statement to SEC for Potential Grail Divestiture )